LEE S PHARMACEUTIC.HD-,05LEE S PHARMACEUTIC.HD-,05LEE S PHARMACEUTIC.HD-,05

LEE S PHARMACEUTIC.HD-,05

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪91.74 M‬EUR
0.013EUR
‪1.94 M‬EUR
‪122.15 M‬EUR
‪192.17 M‬
Beta (1Y)
0.48

About LEES PHARMACEUTICAL HLDGS


CEO
Wanee Leelalertsuphakun
Headquarters
Hong Kong
Founded
1994
FIGI
BBG000BX7C73
Lee's Pharmaceutical Holdings Ltd. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the Proprietary and Generic Products and Licensed-in Products segments. The Proprietary and Generic Products segment is involved in the manufacturing and sales of self-developed and generic pharmaceutical products. The Licensed-in Products segment focuses on the trading of licensed-in pharmaceutical products. The company was founded by Xiaoyi Li in 1994 and is headquartered in Hong Kong.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange LEE S PHARMACEUTIC.HD-,05 stocks are traded under the ticker L1PA.
L1PA reached its all-time high on Mar 5, 2019 with the price of 0.857 EUR, and its all-time low was 0.120 EUR and was reached on Jul 19, 2024. View more price dynamics on L1PA chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track LEE S PHARMACEUTIC.HD-,05 financials in yearly and quarterly reports right on TradingView.
LEE S PHARMACEUTIC.HD-,05 is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
L1PA net income for the last half-year is ‪7.47 M‬ EUR, while the previous report showed ‪67.39 K‬ EUR of net income which accounts for ‪10.98 K‬% change. Track more LEE S PHARMACEUTIC.HD-,05 financial stats to get the full picture.
LEE S PHARMACEUTIC.HD-,05 dividend yield was 1.18% in 2023, and payout ratio reached 63.38%. The year before the numbers were 1.23% and 22.96% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jan 20, 2025, the company has ‪1.06 K‬ employees. See our rating of the largest employees — is LEE S PHARMACEUTIC.HD-,05 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LEE S PHARMACEUTIC.HD-,05 EBITDA is ‪18.13 M‬ EUR, and current EBITDA margin is 10.43%. See more stats in LEE S PHARMACEUTIC.HD-,05 financial statements.
Like other stocks, L1PA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LEE S PHARMACEUTIC.HD-,05 stock right from TradingView charts — choose your broker and connect to your account.